- JNJ Dashboard
- Financials
- Filings
- Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Johnson & Johnson (JNJ) CORRESPCorrespondence with SEC
Filed: 15 May 13, 12:00am
Stephen J. Cosgrove Vice President Corporate Controller | One Johnson & Johnson Plaza New Brunswick, NJ 08933 |
1. | We note your response to prior comment 2. Please confirm that you will revise your disclosure in future filings to replace the reference to the purchase method with the acquisition method. |
2. | We note your response to prior comment 3. Please provide revised disclosure to be included in future periodic reports which includes the useful life information in your response, specifically the weighted asset life for each asset class (Customer Relationships and Patents and Technology) and how the weighted asset lives were determined. |
• | Johnson & Johnson is responsible for the adequacy and accuracy of the disclosure in the filing; |
• | Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to this filing; and |
• | Johnson & Johnson may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
Sincerely, /s/ Stephen J. Cosgrove Vice President Corporate Controller Chief Accounting Officer |